Products for Monitoring Glucose Levels in the Human Body with Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.

Based on favorable technological features, consumer features, and other advantages, several bloodless products are commercially available and promise to enhance diabetes management. Paths for future products are discussed with an emphasis on understanding existing barriers related to both technical and non-technical issues.